Bio Essence Corp (BIOE) stock

BIOEOTCPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 13, 2026Score 9/30

$0.42+0.03 (+7.72%)

Close on Oct 19, 2026Market cap $22.70MP/E 10.5Yield –

Bio Essence profit margin

Profit margin (net margin) is net income as a percentage of revenue.

Bio Essence's profit margin for the twelve months ending Sep 30, 2026 was 44.7%. For fiscal 2025 it was 47.2%, against -404.0% the year before. The highest annual figure on record is 47.2% in fiscal 2025.

Annual profit margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	47.2%	+451.3
FY2024	Dec 31, 2024	-404.0%	−227.8
FY2023	Dec 31, 2023	-176.2%	−46.0
FY2022	Dec 31, 2022	-130.3%	−57.3
FY2021	Dec 31, 2021	-72.9%	−10.8
FY2020	Dec 31, 2020	-62.2%	–

Quarterly profit margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q3 FY2026	Sep 30, 2026	-59.5%	−69.0
Q2 FY2026	Jun 30, 2026	34.0%	+10.9
Q1 FY2026	Mar 31, 2026	41.0%	+968.3
Q4 FY2025	Dec 31, 2025	69.6%	+88.2
Q3 FY2025	Sep 30, 2025	9.5%	+900.1
Q2 FY2025	Jun 30, 2025	23.1%	+540.4
Q1 FY2025	Mar 31, 2025	-927.3%	−725.1
Q4 FY2024	Dec 31, 2024	-18.7%	+90.9
Q3 FY2024	Sep 30, 2024	-890.6%	−838.2
Q2 FY2024	Jun 30, 2024	-517.3%	−410.3
Q3 FY2023	Sep 30, 2023	-202.2%	−98.5
Q2 FY2023	Jun 30, 2023	-109.6%	−52.6
Q1 FY2023	Mar 31, 2023	-52.4%	+23.7
Q4 FY2022	Dec 31, 2022	-107.0%	−64.5
Q3 FY2022	Sep 30, 2022	-103.7%	−23.1
Q2 FY2022	Jun 30, 2022	-57.0%	+12.3
Q1 FY2022	Mar 31, 2022	-76.1%	+23.1
Q4 FY2021	Dec 31, 2021	-42.5%	−1.6
Q3 FY2021	Sep 30, 2021	-80.6%	+9.0
Q2 FY2021	Jun 30, 2021	-69.3%	+20.6
Q1 FY2021	Mar 31, 2021	-99.2%	−61.0
Q4 FY2020	Dec 31, 2020	-40.9%	–
Q3 FY2020	Sep 30, 2020	-89.7%	–
Q2 FY2020	Jun 30, 2020	-89.9%	–
Q1 FY2020	Mar 31, 2020	-38.2%	–